Clayton, Dubilier & Rice, LLC — Q1 2026 13F-HR

← Clayton, Dubilier & Rice, LLC

Q1 2026 · 13F-HR

Clayton, Dubilier & Rice, LLCholdings as filed

Filed 2026-05-08 · accession 0001104659-26-057668

$536.5M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · Clayton, Dubilier & Rice, LLC · Q1 2026

AI · grounded in 13F

Clayton, Dubilier & Rice, LLC closed its position in Agilon Health, Inc. AGL, reducing the holding by $69 million. The fund subsequently established a new position in Agilon Health, Inc. AGL valued at $31.64 million. The fund ended the period with two positions and total assets under management of $536.49 million.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
76118Y104	REZI	Resideo Technologies, Inc.	$504.8M	94.1%	14,976,142	Common	SOLE
00857U206	AGL	Agilon Health, Inc.	$31.6M	5.90%	4,000,000	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.